CymaBay Therapeutics

CymaBay Therapeutics

Developing therapies for liver and other chronic diseases with high unmet medical need.

HQ location
Hayward, United States
Launch date
Employees
Market cap
$3.7b
Enterprise value
$3.5b
Share price
$32.48 CBAY
Authorizing premium user...